disease management Articles
-
A Bayesian decision analysis with fuzzy interpretability for aging chronic disease
This paper presents ideas on the applications of fuzzy concept to decision making for aging chronic disease. A Non-Homogeneous Poisson Process (NHPP) with a power-law intensity function is used in this study. In general, classical Bayesian decision methods presume that future states of nature can be characterised as probability events. However, we do not know what the future will entail ...
-
Managing the risks of bovine spongiform encephalopathy: a Canadian perspective
This paper reviews the history of the risk management challenges faced by many countries and regions of the world which have had cases of bovine spongiform encephalopathy (BSE) from 1986 to the present. The paper first summarises the nature of prion diseases from a scientific perspective, and then presents an overview of the findings of an extensive set of country case studies, devoting special ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management in Spain
Despite the widespread occurrence of bovine spongiform encephalopathy (BSE) in European countries in the late 1990s and the European Commission Scientific Steering Committee (SSC) report that cattle in Spain were likely infected with BSE agent, Spanish authorities continued to consider their country BSE-free. Some key European Union (EU) regulations to reduce BSE risk were enforced with delay, ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management in Belgium
Large imports of cattle and meat and bone meal from countries potentially affected by bovine spongiform encephalopathy (BSE) may have led to the BSE agent entering Belgium, and the occurrence of domestic BSE cases. The first case was confirmed in 1997. The ability to avoid amplification of incoming infectivity, as well as to reduce already circulating infectivity, was greatly improved in Belgium ...
-
Risk management for bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in France: policy analysis and lessons learned
The experience of bovine spongiform encephalopathy (BSE) risk assessment and management in France was somewhat unique among BSE affected countries. Due to its proximity to the UK, the French meat and bone meal industry was challenged with particularly high amounts of infectivity from imported contaminated feed and infected cattle. Although France apparently had an adequate BSE control system ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management strategies in the People's Republic of China
During the late 1970s, the People's Republic of China (PRC) launched a series of far-reaching economic reforms in rural areas of the country in order to develop a market economy; after three decades, these nationwide reforms have achieved enormous success. The country witnessed phenomenal growth in its economic development and became the second largest exporter in the world by 2005. With the ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management in Nordic countries
The prevalence of bovine spongiform encephalopathy (BSE) in Nordic countries is low. To date, there have been 14 BSE cases in domestic cattle in Denmark, three cases in Danish cattle exported to other countries, one case in Finland, one in Sweden, and no cases in Norway. As of April 2008, no cases of variant Creutzfeldt-Jakob disease (vCJD) have been identified. All Nordic countries had stopped ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management in Italy
Italy experienced two imported cases of bovine spongiform encephalopathy (BSE) in 1994 and viewed the disease as a 'foreign' problem. Early, precautionary actions including: a 1989 ban on UK meat and bone meal (MBM), 1990 ban on UK beef, 1994 domestic ban on mammalian MBM to ruminants, and 1996 ban on UK live cattle, protected Italy from a much larger outbreak. In 2001 Italy implemented an ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management in Switzerland
In 1990, Switzerland became the first country in mainland Europe to report a native case of bovine spongiform encephalopathy (BSE), despite a low level of live bovine and meat and bone meal (MBM) imports from the UK, the country generally recognised as the origin of the epidemic. Although an MBM to ruminant feed ban was immediately put into effect, the incidence of BSE continued to increase in ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management in Central European Countries: Czech Republic, Slovakia, Slovenia and Poland
The Czech Republic, Slovakia, Slovenia and Poland are economically stable countries located in the Central and Eastern part of Europe that became European Union Member States on May 1, 2004. These countries reported their first domestic bovine spongiform encephalopathy (BSE) cases in 2001-2002. Several national and European Union legislative measures were adopted by veterinary officials to reduce ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease risk management in the Netherlands
Imports of animal feeds containing contaminated meat and bone meal (MBM) from the UK and other countries in the late 1980s and early 1990s was identified as the major risk factor for an increased risk of bovine spongiform encephalopathy (BSE) entering into the Netherlands. The first BSE case was confirmed in March 1997. Early preventive measures, such as the 1989 domestic ban on ruminant MBM for ...
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease preventive risk management in the Russian Federation
To date, Russia has not reported any cases of bovine spongiform encephalopathy (BSE) or variant Creutzfeldt-Jakob disease (vCJD) in its own territory. Qualitative self risk assessment indicated that if BSE occurred in the Russian Federation, the economic consequences would be devastating for its agriculture and economy. Preventive measures taken by the Russian Government to anticipate and reduce ...
-
Understanding Pediatric Short Bowel Syndrome
As a parent, you want and hope the best for your children. When your child is diagnosed with a severe condition such as Short Bowel Syndrome, you can feel as if your world has turned upside down. Managing their disease and helping your child lead a better life becomes your top priority. For any parent, the first step in supporting your child is to better understand their disease and the ...
-
Glooko Named a Leader by Independent Research Firm in Diabetes Digital Therapeutics for Healthcare Payers
At Glooko, we believe being named a leader in CB Insights’ Diabetes Digital Therapeutics For Healthcare Payers — Execution & Market Strength Positioning (ESP) Vendor Matrix validates what our customers have been saying about our commitment to providing innovative digital health tools for chronic conditions like diabetes. Glooko was among the select companies that CB Insights ...
By Glooko, Inc.
-
The Source for Respiratory Innovation Secured- KoKo, LLC and Galen Data
KoKo, LLC announces a partnership for access to Galen Data’s cloud platform. This new partnership provides KoKo direct and secure connectivity to a compliant cloud infrastructure, allowing access virtually anywhere. The secured data can be made accessible to providers and patients. By harnessing this information, KoKo will be able to develop innovative respiratory health solutions that ...
By KoKo PFT
-
Serum 14-3-3η A Predictor Of Secondary Sjögren’s Syndrome In SLE
Do you have a patient with Systemic Lupus Erythematosus (SLE) that you suspect may also have Sjögren’s Syndrome (SS)? With shared clinical and serological features, overlapping SS with SLE is a comorbidity that is often challenging to identify to promptly assist clinical management. This may also lead to misdiagnoses of other connective tissue disorders. New data on 14-3-3η (eta) ...
-
Principal Care Management: Reimbursement for High-Value Care Management Services
It’s July and OCM has sunset, EOM is another year on the horizon, and you are wondering how to continue supporting your patients during this transitional period. Regardless of whether participating in a value-based care model is on your roadmap, PCM should be. Principal Care Management (PCM)1 is designed to reimburse specialty practices for providing needed care management services to ...
-
Nanostics is Developing and Validating a Simple Blood Test to Predict Severity of COVID-19 Disease in SARS-CoV-2 Positive Patients
Edmonton, Alberta - Nanostics Inc., a diagnostic healthcare company that focuses on developing tests to determine a patient's disease risk, announced today plans to develop and validate ClarityDX COVID-19; a simple blood test to predict the severity of COVID-19 disease in patients. Nanostics, in collaboration with the Canadian BioSample Repository (CBSR) at the University of Alberta and Century ...
-
Dental Problems Often Cause Bad Breath
The Direct Link between Bacterial Plaque, Bad Breath, and Dental problems Bad breath or halitosis, dental decay, periodontal disease, and gingivitis are all caused by the anaerobic bacteria that live in the mouth. Anaerobic means living in the absence of air. These types of bacteria are mostly pathological. Bad breath is the odor produced by bacteria living off food particles, each other and ...
-
Bioconjugation Strategies for Enhancing Drug Delivery and Therapeutic Efficacy
In recent years, bioconjugation has emerged as a powerful strategy for improving drug delivery and enhancing therapeutic efficacy. By linking drugs to various biological entities, such as proteins, antibodies, nanoparticles, or targeting moieties, bioconjugation enables precise and targeted delivery of therapeutic agents to desired sites. This article aims to provide an overview of different ...
By BOC Sciences
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you